title: Biliary stenting in the management of large or multiple common bile duct stones.
abstract: BACKGROUND
  Endoscopic biliary stenting with a plastic stent is often performed to prevent impaction of common bile duct (CBD) stones. The therapeutic effect of a plastic stent placement in terms of reduction in stone size and number has not been established.
  
  
  OBJECTIVE
  The aim of this study was to study the effect of biliary stenting as therapy for CBD stones.
  
  
  METHODS
  Retrospective study.
  
  
  METHODS
  Municipal hospital outpatients.
  
  
  METHODS
  Patients with large (> or = 20 mm) and/or multiple (> or = 3) stones had placement of a 7F double-pigtail plastic stent without stone extraction at the initial ERCP. Approximately 2 months later, stone removal was attempted. The number and size of CBD stones before and after stent placement, stone clearance, complications, and 180-day mortality were evaluated.
  
  
  RESULTS
  Forty patients were studied. Stent placement averaged 65 days (range, 50-82 days). The median number (interquartile range) of stones per patient fell after stent placement (4.0 [3.0] before vs. 2.0 [1.0] after; P < .0001). Characteristically, larger stones became smaller and small stones disappeared (ie, the median stone index decreased from 4.6 [3.0] to 2.0 [1.5]; P < .0001). Stone clearance at the second ERCP was achieved in 37 out of 40 patients (93%). Complications included cholangitis (13%) and pancreatitis (5%) after the second ERCP. No 180-day mortality occurred.
  
  
  CONCLUSIONS
  A retrospective, single-center study.
  
  
  CONCLUSIONS
  Stent placement for 2 months was associated with large and/or multiple CBD stones becoming smaller and/or disappearing without any complications. Stenting followed by a wait period may assist in difficult CBD stone removal.
authors.affiliation: Digestive Disease Center, Showa Inan General Hospital, Komagane, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Horiuchi
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Nakayama
authors.forename: Masashi
authors.initials: M
authors.lastname: Kajiyama
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Kato
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kamijima
authors.forename: David Y
authors.initials: DY
authors.lastname: Graham
authors.forename: Naoki
authors.initials: N
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000379:methods*; D042883:Choledocholithiasis / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D003135:Common Bile Duct / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D012189:Retrospective Studies; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology